Dr. Paul Edward O'Brien MD Hematologist

Dr. Paul O'Brien is a hematologist in Charleston, South Carolina and is affiliated with multiple hospitals in the area, including MUSC Medical Center of Medical University of South Carolina and Ralph H. Johnson Veterans Affairs Medical Center. He received his medical degree from Northwestern University Feinberg School of Medicine and has been in practice for 18 years. He is one of 14 doctors at MUSC Medical Center of Medical University of South Carolina and one of 12 at Ralph H. Johnson Veterans Affairs Medical Center who specialize in Hematology.

Are you Dr. O'Brien? Claim/Edit Profile

Office Location

See Contact Information

Specialty & Clinical Interests

Hematologist: General Hematology

Education & Medical Training

McGaw Medical Center of Northwestern University
Residency, Internal Medicine, 1997–2000

Yale-New Haven Hospital
Fellowship, Medical Oncology, 2001–2004

Northwestern University Feinberg School of Medicine
Class of 1996

Certifications & Licensure

American Board of Internal Medicine
Certified in Internal Medicine

American Board of Internal Medicine
Certified in Medical Oncology

SC State Medical License
Active through 2013

Publications & Presentations

Phase 2 trial of induction gemcitabine, oxaliplatin, and cetuximab followed by selective capecitabine-based chemoradiation in patients with borderline resectable or unresectable locally advanced pancreatic cancer.
Esnaola, N. F.,Chaudhary, U. B.,O'Brien, P.,Garrett-Mayer, E.,Camp, E. R.,Thomas, M. B.,Cole, D. J.,Montero, A. J.,Hoffman, B. J.,Romagnuolo, J.,Orwat, K. P.,Marshall, D. T.

Novel di-tertiary-butyl phenylhydrazones as dual cyclooxygenase-2/5-lipoxygenase inhibitors: Synthesis, COX/LOX inhibition, molecular modeling, and insights into their cytotoxicities.
Ghatak, S.,Vyas, A.,Misra, S.,O'Brien, P.,Zambre, A.,Fresco, V. M.,Markwald, R. R.,Swamy, K. V.,Afrasiabi, Z.,Choudhury, A.,Khetmalas, M.,Padhye, S.

Novel di-tertiary-butyl phenylhydrazones as dual cyclooxygenase-2/5-lipoxygenase inhibitors: Synthesis, COX/LOX inhibition, molecular modeling, and insights into their cytotoxicities.
Ghatak, S.,Vyas, A.,Misra, S.,O'Brien, P.,Zambre, A.,Fresco, V. M.,Markwald, R. R.,Swamy, K. V.,Afrasiabi, Z.,Choudhury, A.,Khetmalas, M.,Padhye, S.

See all 4 publications

Report a Correction — If you are aware of information on this page that is out of date or incorrect, please let us know.

Patient Advice & Support


See More
Our Doctor Finder includes most U.S. physicians. Doctors are not ranked, learn more.

Nearby Hematologists

See all Hematologists near Charleston, SC See all Hematologists in South Carolina

Your Message Has Been Submitted

As part of our research on the correction you submitted, you may be contacted at the email address provided.

Sorry, Your Message Could Not Be Submitted

Please try again later, or E-mail your message to doctors@usnews.com and include the Web address (URL) of the page that contains incorrect information.